Detalles de la búsqueda
1.
Glucosamine Improves Non-Alcoholic Fatty Liver Disease Induced by High-Fat and High-Sugar Diet through Regulating Intestinal Barrier Function, Liver Inflammation, and Lipid Metabolism.
Molecules;
28(19)2023 Oct 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-37836761
2.
Synthesis of Chitosan Oligosaccharide-Loaded Glycyrrhetinic Acid Functionalized Mesoporous Silica Nanoparticles and In Vitro Verification of the Treatment of APAP-Induced Liver Injury.
Molecules;
28(10)2023 May 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-37241887
3.
Anti-Obesity Effect and Mechanism of Chitooligosaccharides Were Revealed Based on Lipidomics in Diet-Induced Obese Mice.
Molecules;
28(14)2023 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-37513467
4.
The Ameliorative Effect of COST on Diet-Induced Lipid Metabolism Disorders by Regulating Intestinal Microbiota.
Mar Drugs;
20(7)2022 Jul 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35877737
5.
Biodegradation and Prospect of Polysaccharide from Crustaceans.
Mar Drugs;
20(5)2022 May 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35621961
6.
Marine Chitooligosaccharide Alters Intestinal Flora Structure and Regulates Hepatic Inflammatory Response to Influence Nonalcoholic Fatty Liver Disease.
Mar Drugs;
20(6)2022 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35736186
7.
The Microstructure, Antibacterial and Antitumor Activities of Chitosan Oligosaccharides and Derivatives.
Mar Drugs;
20(1)2022 Jan 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-35049924
8.
Glucosamine attenuates alcohol-induced acute liver injury via inhibiting oxidative stress and inflammation.
Curr Res Food Sci;
8: 100699, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38420347
9.
Mechanism of action of the bile acid receptor TGR5 in obesity.
Acta Pharm Sin B;
14(2): 468-491, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-38322325
10.
Ameliorating the effect and mechanism of chitosan oligosaccharide on nonalcoholic fatty liver disease in mice.
Food Funct;
14(23): 10459-10474, 2023 Nov 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37921441
11.
Toxicity evaluation of silica nanoparticles for delivery applications.
Drug Deliv Transl Res;
13(9): 2213-2238, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37024610
12.
Research Progress of Design Drugs and Composite Biomaterials in Bone Tissue Engineering.
Int J Nanomedicine;
18: 3595-3622, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37416848
13.
GOS Ameliorates Nonalcoholic Fatty Liver Disease Induced by High Fat and High Sugar Diet through Lipid Metabolism and Intestinal Microbes.
Nutrients;
14(13)2022 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35807929
14.
Anti-obesity effects of galacto-oligosaccharides in obese rats.
Eur J Pharmacol;
917: 174728, 2022 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34965390
15.
Galacto-Oligosaccharide Alleviates Alcohol-Induced Liver Injury by Inhibiting Oxidative Stress and Inflammation.
Metabolites;
12(9)2022 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36144271
16.
The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity.
Front Nutr;
9: 886902, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35662937
17.
Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine.
Front Pharmacol;
13: 829796, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35153797
18.
A new perspective on NAFLD: Focusing on the crosstalk between peroxisome proliferator-activated receptor alpha (PPARα) and farnesoid X receptor (FXR).
Biomed Pharmacother;
154: 113577, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35988420
19.
Advances in the preparation and assessment of the biological activities of chitosan oligosaccharides with different structural characteristics.
Food Funct;
12(3): 926-951, 2021 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33434251
20.
Protective effect and mechanism of chitooligosaccharides on acetaminophen-induced liver injury.
Food Funct;
12(20): 9979-9993, 2021 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-34494629